Scottish Lustre Pure Light acne treatment - YouTube

Introducing Lustre Pure Light - a blue light treatment for acne which allows you to beat spots while carrying on with your life. More information at LustrePureLight.com

Many patients find that their skin improves and their spots seem better when they have been out in the sunshine (ref 1).

However sunlight also contains ultraviolet (UVA-UVB) light which can damage skin and even cause skin cancer.

Scientists have found that visible blue light at a wavelength of 420 nm does not cause damage to the skin but is effective in killing P. acnes, the bacteria which causes acne.

Blue light has been used by dermatologists for many years to treat acne.

Acne drug prevents HIV breakout

Acne drug prevents HIV breakout

Johns Hopkins scientists have found that a safe and inexpensive antibiotic in use since the 1970s for treating acne effectively targets infected immune cells in which HIV, the virus that causes AIDS, lies dormant and prevents them from reactivating and replicating.

The drug, minocycline, likely will improve on the current treatment regimens of HIV-infected patients if used in combination with a standard drug cocktail known as HAART (Highly Active Antiretroviral Therapy), according to research published now online and appearing in print April 15 in The Journal of Infectious Diseases.

"The powerful advantage to using minocycline is that the virus appears less able to develop drug resistance because minocycline targets cellular pathways not viral proteins," says Janice Clements, Ph.D., Mary Wallace Stanton Professor of Faculty Affairs, vice dean for faculty, and professor of molecular and comparative pathobiology at the Johns Hopkins University School of Medicine.

"The big challenge clinicians deal with now in this country when treating HIV patients is keeping the virus locked in a dormant state," Clements adds. "While HAART is really effective in keeping down active replication, minocycline is another arm of defense against the virus."

Read the full article here